AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Enliven Therapeutics, Inc.

$40.63 +$25.09 (+161.45%)
NASDAQ · 08 Oct 2026 20:00 UTC
Previous Close
$41.36
Day Range
$39.25$40.88
Year Range
$14.79$62.32
Market Cap
2.9B
AVG Volume
1.43M
Trailing/Forward PE
-24.77/-
PEG ratio
-4.16
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQUS
Net Income (USD) · Q
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELVN Net Income (USD) by quarter
PeriodNet Income (USD)
26 Q2-32.48M
26 Q1-23.63M
25 Q4-29.67M
25 Q3-20.15M
25 Q2-25.34M
25 Q1-28.54M
24 Q4-23.18M
24 Q3-23.16M
24 Q2-19.95M
24 Q1-22.74M
Operating Income (USD) · Q
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
ELVN Operating Income (USD) by quarter
PeriodOperating Income (USD)
26 Q2-37.21M
26 Q1-27.82M
25 Q4-34.28M
25 Q3-25.1M
25 Q2-28.58M
25 Q1-31.69M
24 Q4-26.9M
24 Q3-27.07M
24 Q2-24.6M
24 Q1-25.99M
EBITDA · Q
Cash Flows · Q
EPS · Q
Expenses · Q
Cash & Debt · Q
Debt ratios · Q
Margins · Q
Return on Capital · Q
Shares Outstanding · Q
Dividends (USD) · Q
Employee Count
Book Value Per Share · Q
Total Assets · Q
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Enliven Therapeutics, Inc.
ELVN
Stockpicker

Video analysis: ELVN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ELVN

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.